Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
97.25    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.10 (0.103%)
Market Cap: £1.54b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Board Changes

28 May 2024 07:00

RNS Number : 9543P
Sirius Real Estate Limited
28 May 2024
 

SIRIUS REAL ESTATE LIMITED

(Incorporated in Guernsey)

Company Number: 46442

JSE Share Code: SRE

LSE (GBP) Share Code: SRE

LEI: 213800NURUF5W8QSK566

ISIN Code: GG00B1W3VF54

 

28 May 2024

Sirius Real Estate Limited

("Sirius Real Estate" or the "Company")

Board Changes

Sirius Real Estate, the leading operator of branded business and industrial parks providing conventional space and flexible workspace in Germany and the UK, announces that James Peggie will step down as an independent non-executive director of the Company at the conclusion of the upcoming annual general meeting in June 2024 ("2024 AGM") and that Deborah Davis will join the Company's Board as an independent non-executive director, with effect from 1 December 2024.

 

Deborah Davis

 

Deborah spent her executive career in Sales, Marketing, Customer experience and Operations at some of the world's largest technology businesses including senior roles at PayPal, eBay, Symantec and Verizon Business. She holds an engineering honours degree in Applied Science (Electronics) from the University of Melbourne, a Masters degree in Science Management with Distinction from London Business School and is a Chartered Director (CDir).

 

Deborah is on the board of two listed companies, as Chair of diagnostic data and analytics company Diaceutics plc and Remuneration Committee Chair and Non-executive Director of consumer credit company International Personal Finance plc. She is also a Non-executive Director of Lloyds Banking Group Insurance/Scottish Widows Insurance Limited and was formerly a Non-executive Director of The Institute of Directors and of Norwegian listed biometrics company IDEX Biometrics ASA. She is also a trustee of the Southern African Conservation Trust.

 

James Peggie

 

James Peggie will step down from the Board and the Audit, Nomination and Remuneration Committees with effect from the conclusion of the 2024 AGM. James has been on the Board of Sirius since November 2012, and has been an outstanding steward of the Company, having overseen its transformation from an AIM-listed £60 million market capitalisation company to the £1.3 billion FTSE 250 and SAPY-indexed company it is today. During his tenure, James was Senior Independent Director for five years, chair of Sirius' Remuneration Committee for six years and also stood in twice as Board Interim Chair.

 

Commenting on the Board changes, Daniel Kitchen, Chair of Sirius Real Estate, said: "Deborah has impressive credentials as a respected board member across a range of listed, private and social enterprise organisations. She specifically brings a wealth of experience in growth, change and digital transformation in some of the largest technology companies in the world and will provide valuable insights as we continue to develop the use of technology in our business parks and our operating platform, as well as with helping us optimise our impact on society. We are confident that Deborah will be a valuable addition to our Board.

James has made an outstanding contribution to the Board during his tenure which started in 2012 when the company was a £60 million AIM-listed company. He has acted as Senior Independent Director, Interim Board Chair, chair of the Remuneration Committee and as a Member of the Audit and Nomination Committees. We thank him for his incredible support to the Company and the management team over the last 12 years."

The announcement has been made in accordance with requirements of the Listing Rule 9.6.11R of the Listing Rules published by the Financial Conduct Authority (the "Listing Rules") and paragraph 3.59 of the JSE Limited ("JSE") Listings Requirements.

For the purposes of LR 9.6.13R of the Listing Rules and paragraph 3.59 of the JSE Listings Requirements, Deborah Davis is currently a non-executive director of Diaceutics plc and International Personal Finance plc and was in the past five years a non-executive director of IDEX Biometrics ASA.

No further disclosures are required under LR 9.6.13R of the Listing Rules and paragraph 3.59 of the JSE Listings Requirements with respect to this appointment.

Deborah Davis and any 'persons closely associated' with her, have no beneficial interest in the Company's ordinary shares of no par value as at the date of this announcement. 

ENDS

For further information:

Sirius Real Estate

Andrew Coombs, CEO / Chris Bowman, CFO

+49 (0) 30 285010110

 

FTI Consulting (Financial PR)

Richard Sunderland / James McEwan / Talia Shirion / Millie James

+44 (0) 20 3727 1000

SiriusRealEstate@fticonsulting.com 

 

NOTES TO EDITORS

About Sirius Real Estate

Sirius is a property company listed on the main and premium market of the London Stock Exchange and the main board of the JSE. It is a leading owner and operator of branded business and industrial parks providing conventional space and flexible workspace in Germany and the U.K. As of 30 September 2023, the Group's portfolio comprised 139 assets let to 9,248 tenants with a total book value of over €2 billion, generating a total annualised rent roll of €184.2 million. Sirius also holds a 35% stake in Titanium, its €350+ million German-focused joint venture with clients of AXA IM Alts.

 

The Company's strategy centres on acquiring business parks at attractive yields and integrating them into its network of sites - both under the Sirius and BizSpace names and alongside a range of branded products. The business then seeks to reconfigure and upgrade existing and vacant space to appeal to the local market via intensive asset management and investment and may then choose to refinance or dispose of assets selectively once they meet maturity, to release capital for new investment. This active approach allows the Company to generate attractive returns for shareholders through growing rental income, improving cost recoveries and capital values, and enhancing returns through securing efficient financing terms.

 

For more information, please visit: www.sirius-real-estate.com

 

Follow us on LinkedIn at https://www.linkedin.com/company/siriusrealestate/

 

Follow us on X (Twitter) at @SiriusRE

 

 

 

JSE Sponsor

PSG Capital

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBVSRSAUVUAR
Date   Source Headline
8th Jul 20193:30 pmRNSHolding(s) in Company
5th Jul 20199:00 amRNSHolding(s) in Company
1st Jul 20197:00 amRNSTotal Voting Rights
18th Jun 20194:15 pmRNSPosting of Annual Report & Notice of AGM
14th Jun 20194:00 pmRNSDirectorate Change
14th Jun 20193:10 pmRNSDirector/PDMR Shareholding
14th Jun 20193:00 pmRNSDirector/PDMR Shareholding
10th Jun 20194:20 pmRNSPosting of Scrip Dividend Circular
10th Jun 20197:00 amRNSDirector/PDMR Shareholding
5th Jun 20194:20 pmRNSDirector/PDMR Shareholding
3rd Jun 20197:01 amRNSAcquisition
3rd Jun 20197:00 amRNSFinal Results
23rd May 20199:00 amRNSHolding(s) in Company
20th May 20191:30 pmRNSHolding(s) in Company
16th May 20197:00 amRNSCapital Markets Day
13th May 20197:00 amRNSSirius completes acquisition of business park
30th Apr 20198:00 amRNSNotice of Results
8th Apr 20197:00 amRNSTrading Statement
4th Apr 20199:30 amRNSTotal Voting Rights
3rd Apr 20197:00 amRNSSirius completes disposal of Bremen Business Park
1st Apr 20192:30 pmRNSHolding(s) in Company
1st Apr 201910:30 amRNSNotice of Trading Update
27th Mar 201910:30 amRNSDEALING IN SIRIUS SECURITIES
21st Mar 20198:00 amRNSDirector/PDMR Shareholding
15th Mar 20193:15 pmRNSDirector/PDMR Shareholding
14th Mar 20197:00 amRNSAcquisition of business park in Bochum
13th Mar 201910:15 amRNSDirector Declaration
11th Mar 20193:15 pmRNSAdmission of New Shares
6th Mar 20193:10 pmRNSAllotment of New Shares
1st Mar 20197:00 amRNSSirius joint venture with AXA Investment Managers
22nd Jan 20192:30 pmRNSDirector/PDMR Shareholding
21st Jan 20193:00 pmRNSHolding(s) in Company
18th Jan 20193:00 pmRNSAdmission of Scrip Shares & Scrip Circular Update
15th Jan 20193:15 pmRNSDirector/PDMR Shareholding
11th Jan 20193:15 pmRNSAllotment of Scrip Dividend
7th Jan 20191:00 pmRNSTotal Voting Rights
20th Dec 201812:30 pmRNSHolding(s) in Company
12th Dec 20182:00 pmRNSCREST Enabled for Dividend Payments
7th Dec 201812:35 pmRNSDirector/PDMR Shareholding
5th Dec 20182:00 pmRNSResult of General Meeting
28th Nov 201810:00 amRNSDirector/PDMR Shareholding
26th Nov 20183:05 pmRNSScrip Dividend Reference Price and Exchange Rate
20th Nov 20181:00 pmRNSDirector/PDMR Shareholding
19th Nov 20187:00 amRNSHalf-year Report
14th Nov 20182:30 pmRNSSirius completes sale of Bremen Hag Business Park
14th Nov 201810:00 amRNSGeneral Meeting - Forms of Proxy
12th Nov 20183:30 pmRNSGeneral Meeting - Posting of Circular
6th Nov 20181:00 pmRNSBoard Committee Changes
5th Nov 20188:00 amRNSNotice of Half-Year Results
18th Oct 201811:30 amRNSAuditor JSE Accreditation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.